Podcast
Leonard Pickard
Hosted by Leonard Pickard · EN
This channel features a range of podcasts exploring the frontiers of biotechnology, psychedelics, artificial intelligence, creativity, cognitive enhancement, and more.
We interview CEOs, researchers, philanthropists, and public intellectuals who are shaping the questions—and sometimes the controversies—about what may come.
Here, you’ll encounter talented, passionate, and visionary individuals.
Join us to share in the green-growing edge of life and courageous thought, as we explore the potential futures of our species.
William Leonard Pickard
13episodes
Episodes
Newest firstAll episodes
JLS Podcast: Hamilton Morris on Psychedelics, Pharmacopeia, and the Future of Research
Sep 3001:05:45Tap to summarize🎙️ JLS Fund Podcast: William Leonard Pickard in conversation with Hamilton Morris🚀 Background on Hamilton Morris: Journalist, documentarian, and creator of the Hamilton’s Pharmacopeia series, known for exploring the cultural, chemical, and human dimensions of psychedelics.🧠 Inside Hamilton’s Pharmacopeia Morris shares the vision behind his groundbreaking series, the ethical dilemmas faced in filming, and the delicate balance between storytelling and scientific responsibility. His work highlights the voices of chemists, users, and communities often overlooked in mainstream narratives.💊 Big Pharma & Medicalization The discussion explores the role of pharmaceutical companies in psychedelic research, the misconceptions surrounding medicalization, and the broader implications for accessibility and equity in treatment.🚨 Behind the Scenes at the DEA Pickard and Morris reflect on Morris’s rare visit to the DEA headquarters, unpacking insights about policy, enforcement, and the contradictions inherent in the regulation of psychedelics.🌿 Community & Collaboration Beyond the science and politics, the conversation emphasizes the importance of community in psychedelic culture—how collaboration, shared knowledge, and personal experience continue to shape the future of the field.🔍 What’s Next The two visionaries speculate on the trajectory of psychedelic research, from evolving scientific studies to the cultural shifts redefining how society views these substances.🏆 Final Takeaways This dialogue offers a rare blend of personal reflection and cultural critique, spotlighting both the promise and the pitfalls of a rapidly changing psychedelic landscape.✨ Support this work and unlock exclusive interviews with pioneers like Hamilton Morris, William Leonard Pickard, and other leaders in psychedelic science and culture on Patreon: / thelastalchemist 🔗 Stay tuned for more updates from the frontlines of psychedelic research, culture, and storytellingSupport the show
Transcribe →
JLS Podcast: Jonathan Sporn on Building the Future of Psychedelic Medicine
Aug 2501:01:01Tap to summarizeIn this inaugural interview for the JLS Podcast, we speak with Jonathan Sporn — CEO of Gilgamesh Pharmaceuticals, Harvard MD, and former Pfizer researcher. From partnering with Columbia University chemists to designing novel psychedelic-inspired molecules to leading one of the largest biotech deals in history with AbbVie, Sporn brings vision, innovation, and scientific rigor to the frontier of psychedelic medicine. Tune in to explore the cutting edge of drug development, neuroplasticity, and transformative therapies.Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:https://www.patreon.com/c/thelastalchemistSupport the show
Transcribe →
JLS Podcast: Bryan Hubbard on Ibogaine, Policy Innovation, and Addiction Healing
Aug 2500:48:51Tap to summarizeIn this interview, we speak with Bryan Hubbard — legal expert, policy leader, and Executive Director of the American Ibogaine Initiative, as well as CEO of Americans for Ibogaine, a nonprofit advancing research into ibogaine’s neurorestorative potential.From securing $50 million in state-backed funding for ibogaine research in Texas to shaping national drug policy and advocating for underserved communities, Hubbard brings vision, strategy, and heart to the frontier of psychedelic medicine. His work bridges law, science, and public trust while opening new pathways for addiction treatment, PTSD recovery, and neurorestoration.Tune in to explore the cutting edge of psychedelic advocacy, drug policy, and transformative healing.Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:https://www.patreon.com/c/thelastalchemistSupport the show
Transcribe →